The Net Margin of Immunoprecise Antibodies Ltd (IPA.V) is -40.98%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2021-04-30 | -40.98% |
2020-04-30 | -35.19% |
2019-04-30 | -69.72% |
2018-04-30 | -95.03% |
2017-04-30 | -204.67% |